Top

memo - Magazine of European Medical Oncology

Published in:

Open Access 01-09-2018 | special report

Demystification of palliative care: what palliative care teams don’t want you to think about them

Authors: Eva K. Masel, MD, PhD, MSc, Gudrun Kreye, MD

Published in: memo - Magazine of European Medical Oncology | Issue 3/2018

Summary

There is robust data that palliative care is prolonging life while there are still prejudices towards this discipline that have to be demystified. Patients, relatives and caregivers benefit from the concept of early integration of palliative care and therefore, palliative care should not be mainly regarded as end-of-life care.

Pandve HT, Fernandez K, Chawla PS, Singru SA. Palliative care—need of awareness in general population. Indian J Palliat Care. 2009;15:162–3.CrossRefPubMedPubMedCentral

Brennan F. “To die with dignity”: an update on palliative care. Intern Med J. 2017;47:865–71.CrossRefPubMed

Kaasa S, Loge JH. Early integration of palliative care—new evidence and old questions. Lancet. 2018;19(3):280–1. https://doi.org/10.1016/S1470-2045(18)30061-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29402702.CrossRefPubMed

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed

Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017;35:834–41.CrossRefPubMed

Greer JA, Jackson VA, Meier DE, Temel JS. Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin. 2013;63:349–63.CrossRefPubMed

Bauman JR, Temel JS. The integration of early palliative care with oncology care: the time has come for a new tradition. J Natl Compr Canc Netw. 2014;12(12):1763–71. quiz 1771.CrossRefPubMedPubMedCentral

Masel EK, Berghoff AS, Schur S, Maehr B, Schrank B, Simanek R, et al. The PERS2ON score for systemic assessment of symptomatology in palliative care: a pilot study. Eur J Cancer Care (engl). 2016;25:544–50.CrossRef

Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, et al. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18:e543–e51.CrossRefPubMed

10.

Burki TK. End-of-life discussions and care received. Lancet Oncol. 2013;14:16.CrossRefPubMed

11.

Garner KK, Henager AA, Kirchner JE, Sullivan DH. The elephant in the room: facilitating communication at the end of life. Fam Med. 2011;43:277–8.PubMed

12.

Oostendorp LJM, Ottevanger PB, van de Wouw AJ, Schoenaker IJH, de Graaf H, van der Graaf WTA, et al. Expected survival with and without second-line palliative chemotherapy: who wants to know? Health Expect. 2014;18(6):2903–14. https://doi.org/10.1111/hex.12275.CrossRefPubMedPubMedCentral

13.

Enzinger AC, Zhang B, Schrag D, Prigerson HG. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J Clin Oncol. 2015;33(32):3809–16.CrossRefPubMedPubMedCentral

14.

Masel EK, Kitta A, Huber P, Rumpold T, Unseld M, Schur S, et al. What makes a good palliative care physician? A qualitative study about the patient’s expectations and needs when being admitted to a palliative care unit. PLoS ONE. 2016;11:e158830.CrossRefPubMedPubMedCentral

15.

Hui D, Kim YJ, Park JC, Zhang Y, Strasser F, Cherny N, et al. Integration of oncology and palliative care: a systematic review. Oncologist. 2015;20:77–83.CrossRefPubMed

16.

LeBlanc TW, El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program. 2015;2015(1):471–8. https://doi.org/10.1182/asheducation-2015.1.471.PubMedCrossRef

17.

Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 2015;1:778–84.CrossRefPubMedPubMedCentral

18.

Haun MW, Estel S, Rücker G, Friederich H‑C, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;6:CD11129.PubMed

Title: Demystification of palliative care: what palliative care teams don’t want you to think about them
Authors: Eva K. Masel, MD, PhD, MSc
Gudrun Kreye, MD
Publication date: 01-09-2018
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 3/2018
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-018-0420-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Summary

Please log in to get access to this content

Other articles of this Issue 3/2018

Current and evolving treatment strategies in adult immune thrombocytopenia

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis

Cure in metastatic breast cancer

Post SABCS local therapy and radiology

Cure in metastatic disease: how to manage and who is the right patient in GIST

Adenoid cystic carcinoma of the sublingual salivary gland obstructing the submandibular salivary gland duct

Keynote webinar | Spotlight on antibody–drug conjugates in cancer